InvestorsHub Logo

Viperciara

05/27/15 4:53 PM

#1827 RE: James salmon #1824

I can not believe they need it for NBS20 as they state!! I just bought a shit load today and it is down
Neostem, Inc. (NBS) After Hours Trading $2.35 or -.28 a share or -10.65%

I would not have bought today if I knew they needed money still

Why did they say >>Dr. David J. Mazzo, NeoStem’s Chief Executive Officer. “The grant substantiates our approach to identifying and securing non-dilutive funding for our development programs and helps position NeoStem as a leader among immuno-oncology therapy developers.” - See more at: http://www.neostem.com/media/press-releases/news-item/major-grant-advances-pioneering-melanoma-therapy-at-neostem/#sthash.mW5TgI9x.dpuf